GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inari Medical Inc (STU:IM7) » Definitions » EPS (Diluted)

Inari Medical (STU:IM7) EPS (Diluted) : €-1.24 (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Inari Medical EPS (Diluted)?

Inari Medical's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was €-0.28. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.24.

Inari Medical's EPS (Basic) for the three months ended in Sep. 2024 was €-0.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was €-1.24.

Inari Medical's EPS without NRI for the three months ended in Sep. 2024 was €-0.20. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.96.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Inari Medical's highest 3-Year average EPS without NRI Growth Rate was -379.10% per year. The lowest was -379.10% per year. And the median was -379.10% per year.


Inari Medical EPS (Diluted) Historical Data

The historical data trend for Inari Medical's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inari Medical EPS (Diluted) Chart

Inari Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -0.03 0.22 0.16 -0.52 -0.03

Inari Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 -0.07 -0.39 -0.50 -0.28

Competitive Comparison of Inari Medical's EPS (Diluted)

For the Medical Devices subindustry, Inari Medical's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inari Medical's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inari Medical's PE Ratio distribution charts can be found below:

* The bar in red indicates where Inari Medical's PE Ratio falls into.



Inari Medical EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Inari Medical's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.5-0)/56.771
=-0.03

Inari Medical's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-16.549-0)/58.366
=-0.28

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Inari Medical  (STU:IM7) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Inari Medical EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Inari Medical's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Inari Medical Business Description

Traded in Other Exchanges
Address
6001 Oak Canyon, Suite 100, Irvine, CA, USA, 92618
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Inari Medical Headlines

No Headlines